19 June 2013
Keywords: cv, therapeutics, ranexa, filed, eu, usa, submitted
Article | 05 April 2004
CV Therapeutics of the USA has submitted a Marketing Authorization Application to the European Medicines Evaluation Agency for the use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.